What is USRM's gross margin?

U.S. Stem Cell (USRM) has a gross margin of 75% and a net margin of -2837%.

What is USRM's P/E ratio?

Track U.S. Stem Cell (USRM) P/E ratio, ROE, and valuation metrics over time.

Where can I see USRM's full financials?

See U.S. Stem Cell (USRM) income statement, cash flow, and balance sheet — quarterly and annual — alongside insider trading activity.

U.S. Stem Cell (USRM) Financials — Revenue, Earnings, Cash Flow

$0.00

+0.00 (+0.00%)

OTC · Healthcare · Biotechnology · Tech Score Sell · Power 40 · $64151 mcap · 564M float · 0.014% daily turnover

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

📊 Key Metrics

TTM

$0M

Revenue

-59.1% YoY

$-3M

Net Income

+13.1% YoY

$-0M

Free Cash Flow

+71.2% YoY

75.4%

Gross Margin

-1873.6%

Op. Margin

-2836.8%

Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE20.8%

ROA-4801.7%

ROIC23.4%

Valuation

P/E-0.0

P/B-0.0

EV/EBITDA-5.4

Leverage

Debt/Equity-0.61

Current Ratio0.00

Interest Cov.-3.1x

Quality Scores

Piotroski F5/9

Altman Z-3283.42

Beneish M-175.27